Alnylam Pharmaceuticals (ALNY) Q2 2017 Results – Earnings Call Transcript ALNY Beats EPS Alnylam Pharmaceuticals (NASDAQ:ALNY): Q2 EPS of -$1.07 beats by $0.15. Revenue of $15.9M (+82.5% Y/Y) misses by $6.41M. Executives Christine Regan Lindenboom – Alnylam Pharmaceuticals, Inc. John M. Maraganore, Ph.D. – Alnylam Pharmaceuticals, Inc. Akshay K. Vaishnaw – Alnylam Pharmaceuticals, Inc. Manmeet Singh Soni
Complete Reading

Chart | Calendar   | TRADE NOW | GOLD Gold   | Data | Chart | Calendar | Forecast | News BUZ INVESTORS  Gold decreased 1.27 USD/t oz. or 0.10% to 1,262.42 on Tuesday June 13 from 1,265.02 in the previous trading session. Historically, Gold reached an all time high of 1898.25 in September of 2011 and a
Complete Reading

Chart | Calendar   | TRADE NOW | SILVER Silver  | Data | Chart | Calendar | Forecast | News source: tradingeconomics.com BUZ INVESTORS  Silver increased 0.10 USD/t. oz or 0.54% to 17.68 on Thursday June 8 from 17.55 in the previous trading session. Historically, Silver reached an all time high of 49.45 in January of 1980
Complete Reading

Chart | Calendar   | TRADE NOW | USDJPY Japanese Yen| Data | Chart | Calendar | Forecast | News The USDJPY increased 0.1050 or 0.10% to 109.8950 on Thursday June 8 from 109.7900 in the previous trading session. Historically, the Japanese Yen reached an all time high of 306.84 in December of 1975 and a record
Complete Reading

Chart | Calendar   | TRADE NOW | GOLD Gold  | Data | Chart | Calendar | Forecast | News source: tradingeconomics.com BUZ INVESTORS  Gold increased 1.27 USD/t oz. or 0.10% to 1,278.22 on Monday June 5 from 1,279.58 in the previous trading session. Historically, Gold reached an all time high of 1898.25 in September of 2011
Complete Reading

Create Account



Log In Your Account